New Technological Innovations during COVID-19 Pandemic to Spur the Growth of Viral Disease Diagnosis Market

As COVID-19 continues to affect the global populace, the diagnosis of the novel coronavirus for speedy recovery has become the need of the hour. Therefore, the COVID-19 pandemic may prove to be a growth accelerator for the viral disease diagnosis market.  Viruses, including coronaviruses are tiny organisms made up of genetic material–either DNA or RNA. Viral disease diagnosis is significant to alleviate the pandemic risk. The diagnosis helps in identifying the viral pathogens to monitor and apply necessary therapy for treatment and to prevent further transmission of the disease.

Get Sample Copy of this Report @

Novel technologies springing up for speedy COVID-19 diagnosis

To enable speedy of COVID-19 testing, assay manufacturers and researchers are coming up with numerous new techniques.  For instance, South Korea was able to contain coronavirus cases due to timely and speedy testing with Allplex 2019-nCoV Assay, a testing kit by a Seoul based biotechnology firm, Seegene. Due to speedy testing, South Korea recorded 10284 cases and due to early detection, 6598 patients have successfully recovered. Therefore, it has eventually led to the flattening of the curve of infected patients.

Rapid point-of-care tests are also on the rise. Recently, Cepheid Xpert Xpress, a small portable device for quick screening has been launched. In addition finger prick test such as VivaCheck Biotech’s VivaDiag SARS-CoV-2 IgM/IgG rapid test is also a classic instance describing the rise in rapid testing measures. Such developments further augur the demand for diagnostic kits and will prove to be a boon for increasing the growth rate of the viral disease diagnosis market.

Check Table of Contents of this Report @

The COVID-19 pandemic has increased the demand for diagnosis drastically.  The World Health Organization (WHO) has also urged all the healthcare agencies to make the testing for COVID-19 pandemic a top priority. This, in turn, increases the demand for viral disease diagnosis testing. In addition, a blend of regulations and quick approvals by governments of various countries will also help the viral disease diagnosis market to a great extent.

Viral Disease Diagnosis Market Growth to be Fuelled by 2025

Global Viral Disease Diagnosis Market: Snapshot

Thousands of deaths are occurring on a yearly basis on account of various viral infectious diseases. Some of the viral diseases occurring are rabies, avian influenza, HIV-1, measles, enterovirus, poliovirus, coronavirus, and Metapneumovirus. This has resulted in global public health concerns. Common influenza, contagious infections, and serious pandemics are some of the issues that need clinical prognosis for an early detection of the infectious agent. It is thus essential to identify the viral pathogens so as to prevent transmission, make use of the necessary therapy, and monitor the effect of the therapy. This will ultimately lead to disease diagnosis, management, and control.

The report identifies latest technological advancements in viral diagnosis such as mass spectrometry, polymerase chain reaction, and next generation sequencing. It discusses how these new viral diagnosis methods are being applied for the identification and management of viral disease diagnosis. Such new advancements have revolutionized clinical viral disease diagnosis and can efficiently and quickly detect viral pathogens.

Request Sample Copy of the Report @

The study also discusses key challenges facing the global viral disease diagnosis market such as high cost, which is limiting the use of these diagnostics in many laboratories and healthcare centers. High cost is especially becoming a problem in resource limited settings. However, the emergence of microfluidic technology is attracting many biomedical research groups and is estimated to hold immense growth potential in the field of viral disease diagnosis. Moreover, this technology can be a cost effective means to diagnose viral disease.

Global Viral Disease Diagnosis Market: Overview 

Viruses are minute organisms that are made up of genetic material and can cause infection in the body. These viruses invade and attach themselves to a host cell, thus killing or altering the function of that cell. This results into an infection in the human body. There are several ways by which viruses can be transmitted such as contact with infected person, and unsafe sex. Poor personal hygiene also increases the risk of virus infection.

Request TOC of the Report @

Viral disease diagnosis is crucial to reduce the risk of epidemics and to provide treatment in a timely manner. High burden of viral diseases continues to be a public concern across communities in the world.

The report is presented collecting data from industry-centric databases and using validated analytical tools for scrutiny of the information.

Global Viral Disease Diagnosis Market: Drivers and Restraints 

The increasing incidence of viral infections, clinical research, and technological advances in molecular diagnostics are some of the major factors driving the global viral disease diagnosis market. Moreover, development of precise rapid screening tests with improved detection time and choice of effective treatments is further propelling the market’s growth.

Read Comprehensive Overview of Report@

However, continuous variation in viral genome and varied environmental conditions lead to several strains of viruses which may challenge the utilization of existing viral disease diagnostic tests. Moreover, lack of expertise, low awareness about diagnostic tests, and limited availability of virological laboratories especially in developing countries may result in underutilization of viral disease diagnostic tests by clinicians.

Global Viral Disease Diagnosis Market: Market Segmentation 

The global viral disease diagnosis market is segmented on the basis of diagnostic test, end users, virus type, and geography. On the basis of diagnostic test, specimen examination, serodiagnostic tests, and viral isolation are the segments of the market. Specimen examination involves direct examination of specimen for presence of virus antigen using light microscopy, electron microscopy, and various molecular techniques. Serodiagnostic tests involve several serological methods to detect virus specific immunogens or viral antigens. The sub-segments of serodiagnostic tests are complement fixation test, hemagglutination inhibition test, particle agglutination, single radial hemolysis, western blot, immunofluorescence technique, neutralization test, ELISA, line immunoassay, and recombinant immunoblot assay (RIBA).

By end users, physician offices, commercial laboratories, physician offices, and nursing homes are the segments of the global viral disease diagnosis market. By virus type, Adenovirus, Cytomegalovirus, Dengue virus, Enterovirus, Hepatitis virus (HAV, HCV, HBV), HIV-1, Human Coronavirus, Human Metapneumovirus, Human Rhinovirus A, Measles Virus, Poliovirus, Rabies virus, Varicella Zoster virus, Avian Influenza, Coxsackievirus, Epstein-Barr virus (EBV), Lymphocryptovirus, Herpes virus (HSV-1, HSV-2), HIV-2, Human Herpesvirus, Human Papillomavirus (HPV), Influenza virus, Mumps virus, Rubella virus, Syncytial virus (RSV), West Nile virus, and others are the segments of the market.

By geography, the report divides the global viral disease diagnosis market into North America, Asia Pacific, Europe, and Rest of the World.

Companies Mentioned in Report

The report mentions and profiles top companies operating in the global viral disease diagnosis market, namely Abbott Laboratories, Cepheid, Roche Diagnostics, Thermo Fischer Scientific, bioMerieux, Becton Dickinson and Company, Affymetrix, Novartis Diagnostics, and Siemens AG.

Urgent Need for Quick Identification of Diseases Spikes Demand

San Francisco, California, July 18, 2017: TMR Research offer a comprehensive outlook of the global viral disease diagnosis market through its latest publication. The research report, titled “Viral Disease Diagnosis Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025,” sheds light on the strengths, weaknesses, opportunities, and threats guiding the trajectory of the overall market. Emergence of various viral disease has led to significant rise in the demand for viral disease diagnosis solutions. The growing concerns about repercussions of viral diseases has spiked the awareness and urgency of early detection.

In the recent years, the incidence of rabies, influenza, HIV-1, poliovirus, zika, sars, and enterovirus has resulted in an urgent need for timely disease diagnosis, control, and management. The rapid pace of technological advancements, ongoing clinical research, and ever-changing environmental conditions are also expected fuel the growth of the global viral disease diagnosis market. The various tests available in the global market are serodiagnostic tests, viral isolation tests, and specimen examination tests. The growing investments in clinical research has significantly improved the diagnostic tools used for identifying the viral diseases in recent years.

In terms of geography, the global viral disease diagnosis market is segmented into North America, Europe, Asia Pacific, and Rest of the World. While the developed region such as North America and Europe are expected to be the key contributors, the developing regions are also expected to stand out. High level of awareness, better medical facilities, supportive government policies, and growing health concerns in developed regions are expected to keep the regional markets at the forefront. On the other hand, the growing unmet medical needs, increasing investment of pharmaceutical companies, and changing healthcare infrastructure in developing countries is expected to make Asia Pacific a key regional market in the coming years. Rest of the World, such as Africa and the Middle East is also anticipated to offer lucrative opportunities to the global market.

Some of the leading players operating in the global viral disease diagnosis market are bioMerieux, Abbott Laboratories, Thermo Fischer Scientific, Cepheid, Roche Diagnostics, Becton Dickinson and Company, Novartis Diagnostics, Affymetrix, and Siemens AG. The research report provides a detailed analysis of the competitive landscape present in the global viral disease diagnosis market. It also highlights the threat from alternatives and substitutes as well as from new entrants. The publication offers a valuable insight into the business and marketing strategies, research and development plans, and expansion plans of the key players operating in the global market. Additionally, it also includes comments and recommendations from expert market leaders to give the readers a holistic overview of the market dynamics.